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Most studies concerning a possible protective role ofcarot- 
enoids against cancer focus on serum carotenoid levels. W e  
have used Raman microspectroscopy to study the intracellu­
lar amounts of carotenoids in lymphocytes of lung cancer 
patients and of healthy individuals. Our results indicate a 
significant decrease of carotenoids in lung carcinoma patients 
compared with healthy individuals, particularly in adenocarci­
noma patients. Carotenoid supplementation raised the se­
rum concentration in 2 lung cancer patients up to normal 
levels, whereas intracellular content remained significantly 
lower. This indicates that carotenoid uptake by lymphocytes 
is not only dependent on serum carotenoid concentration. 
Our findings indicate that Raman microspectroscopy, a re­
cently developed technique to measure intracellular levels of 
drugs, is also well suited to obtain quantitative data on 
carotenoid amounts inside cells. Int. J. Cancer 74:20-25.
© 1997 Wiley-Liss, Inc.
Numerous studies indicate that low serum carotenoid concentra­
tion and a low dietary intake of carotenoids are related to an 
increased risk of cancer, especially lung and stomach cancer (Peto 
et al., 1981; Ziegler, 1989; Bendich, 1990; van Poppel, 1993; 
Krinsky, 1993). Three different mechanisms have been suggested 
to explain the protective effect of carotenoids: provitamin A 
activity (Lotan, 1980; Lupulescu, 1993), singlet oxygen and radical 
quenching (Burton and Ingoîd, \ 984; Krinsky, 1989) and modula­
tion of the immune system (Alexander et al., 1985; Jyonouchi et
ah, 1991).
Some of the problems that arise when assessing the relationships 
between cancer risk in humans and serum carotenoid concentra­
tions are related to the large fluctuations of the latter, which depend 
on intake, and also the fact that dietary intake does not reflect the 
actual uptake in serum. Observations that carotenoids can modulate 
the immune system prompted us to investigate whether differences 
might exist between the carotenoid contents of lymphocytes of 
healthy individuals and of cancer patients and how this relates to 
the concentration of carotenoid in serum,
We have shown that Raman micro spectroscopy is a sensitive 
technique for analysis o f the carotenoid content of human lympho­
cytes (Puppels et a i , 1993). We found that the highest carotenoid 
concentration for healthy donors was observed in the Gall body, a 
cytoplasmic (lipid) spherule, present in some CD4+ and CD8+ 
cells (Gall, 1936; Bessis, 1973). The carotenoid concentration 
inside the Gall body was found to be about 1,000 times higher than 
the serum concentration. Such high carotenoid concentration in the 
Gall bodies of healthy donors indicates that Gall bodies are storage 
sites for carotenoids. In the present study we used Raman 
microspectroscopy to investigate whether differences exist in Gall 
body carotenoid concentration in lymphocytes of lung cancer 
patients and healthy donors. The effect of dietary ß-carotene 
supplementation on serum and intracellular carotenoids was inves­
tigated in a healthy individual and in 2 lung cancer patients.
MATERIAL AND METHODS 
Raman micro spectroscopy
Raman microspectroscopy is a spectroscopic technique that can 
be used to obtain information about the molecular composition of a
sample with a spatial resolution equal to that of a normal optical 
microscope. Raman scattering is a process in which there is energy 
transfer between the incident light and the scattering molecules. In 
most cases, the photons transfer some energy to the scattering 
molecule, which brings the molecule to one of the higher vibra­
tional energy levels. The energy loss of the scattered photons 
results in a wavelength shift that is characteristic for that vibration 
of the molecule. The Raman spectrum therefore gives a fingerprint 
of (all excitable vibrational levels of) the molecules in the 
measuring volume. The intensity of a Raman line is linearly 
dependent on the concentration of molecules (with that particular 
vibration) in the sample. The wavelength shifts of a Raman line, 
relative to the laser line, are expressed in cm“ 1: Acm-1 = 
[l/\in — 1/XquJ x 107 (with \ in nm), Carotenoids are strong 
Raman scatterers, especially the single and double conjugated 
carbon bond-stretches, which give rise to large Raman peaks at 
about 1,150 and 1,525 cm "1, respectively. All carotenoids present 
in humans give similar spectra, with small changes due to 
differences in structure, The peak at about 1,150 cm" 1 is present for 
all carotenoids.
For determination of the carotenoid content of Gall bodies, we 
used a normal (non-confocal) Raman microscope with 63 X water 
immersion objective. Figure la  shows a schematic drawing of the 
set-up used in our study. Red light (647 nm) was used to minimize 
bleaching of the carotenoids. All measurements were carried out 
using the same conditions: 4 mW laser light on the sample and 15 
sec photon collection time on the camera. Figure lb  shows a 
photograph of a lymphocyte containing a Gall body. In Figure 1 c a 
typical spectrum obtained from a Gall body of a healthy individual 
is shown.
Calibration of the peak height vs. the concentration was done 
using solutions of ß-carotene in tetrahydrofuran (THF) with 
different molarities (data not shown). From the background sub­
tracted peak heights at 1,150 cm-1, it was calculated that the peak 
intensity is about 1,600 counts/mM ß-carotene for the conditions 
used in our study, the detection limit being about 5 mM.
Preparation of samples
Peripheral blood of healthy volunteers and of lung cancer 
patients was collected in the morning by venipuncture in the arm, 
using a siliconized Vacutainer to collect serum and a heparinized
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Vacutainer to collect white blood cells. Serum was isolated after 
centrifugation, and lymphocytes were isolated using the Ficoll- 
Paque method (Böyurn, 1968). Serum was collected simulta­
neously and stored in the dark at — 80°C until analysis using 
high-performance liquid chromatography (HPLC). Part of the 
isolated lymphocytes was immuno-stained with CD4-PE and 
CD8-FITC (Becton Dickinson, San Jose, CA) and analyzed with a 
fluorescence microscope.
Fluorescence microscopy
A fluorescence microscope (Nikon, type Optiphot EF) with blue 
light excitation was used to study the im mu no-labeled lympho­
cytes; 100 cells of each sample were counted to determine the 
relative amounts of CD4H' and CD8* lymphocytes. In addition, the 
number of Gall bodies was counted and their diameter was 
measured in all cells, using a calibrated eyepiece micrometer.
HPLC
Serum samples were analyzed for the presence of carotenoids, 
using HPLC, at the T.N.O. Research Laboratory, Zeist, The 
Netherlands, as described previously (van Vliet et al, 1991). 
Amounts of the 5 major carotenoids present in humans (ß-carotene, 
a-carotene, lycopene, ß-cryptoxanthine and lutein/zeaxanthin) 
were determined.
ß-carotene supplementation
Dietary supplementation was given in the form of capsules with
25 mg crystalline ß-carotene, generously provided by Merck 
(Darmstadt, Germany). Because the actual uptake of crystalline 
ß-carotene is low, a high dose of 100 mg/day (intake at one meal) 
was chosen to obtain clear responses compared with the normal 
dietary intake of ß-carotene. Cells and serum of all individuals 
were measured prior to the study to establish baseline levels. Blood 
samples were drawn on days 1, 2, 3, 5, 8, 13 and 17 after the first 
supplementation.
Statistical analysis
The significance of differences between the groups of healthy 
donors and lung cancer patients was calculated for all measured 
parameters using an unpaired double-tailed Mest.
RESULTS
The first part of this pilot study focused on possible differences 
in the carotenoid content of Gall bodies comparing healthy persons 
with lung cancer patients. From 23 healthy donors, and 19 donors 
with different types of lung cancer, peripheral blood was collected 
as described above; lymphocytes were isolated and measured 
within 24 hr. The results are summarized in Table I. The differences 
between the 2 groups are clear and significant. The 2 groups were 
not age matched: if the age-matched part of the group of healthy 
donors (n = 11) is compared with the lung cancer group, only the 
difference in average Raman intensities remains (p <  0.05). These 
findings suggest that carotenoid concentrations decrease with age.
The individual values of the total serum carotenoid concentra­
tions, measured with HPLC, are shown in Figure 2a. This clearly 
shows that the differences between the “all healthy” and “lung 
cancer” groups are significant, whereas the difference between the 
age-matched groups “healthy old” and “lung cancer” is not. The 
individual values of the average Gall body carotenoid concentra­
tions, measured with Raman microspectroscopy, are shown in 
Figure 2b. Here also, the differences between “healthy old” and 
“lung cancer” are significant.
There is a positive correlation between the individual serum 
carotenoid and Gall body concentrations, although the correlation 
coefficients are low (total 0.47; healthy 0.36; lung cancer 0.25).
The second part of our study focused on the influence of 
short-term high-dose ß-carotene supplementation on the carot-
TABLEI - MAIN DIFFERENCES BETWEEN HEALTHY PERSONS AND LUNG
CANCER PATIENTS FOR THE PARAMETERS MEASURED
Healthy Lung cancer
P l(n = 23) (n = 19)
x ± SD x ± SD
% cells with GBs 22.0 ± 12.6 16.0 ± 6.2 <0.05
Average number of 1.11 ± 0.15 1.00 ± 0.21 <0.05
GBs/cell
Average GB Raman 101.7 ± 62.9 50.3 ± 31.3 <0.005
intensity
<0.05Total GB carotenoid 2.88 ± 3.5 0.63 ± 0.7
content2
Serum lutein 0.33 ± 0.14 0.25 ± 0.12 <0.05
Serum ß-cryptoxan­ 0.28 ± 0.24 0.24 ± 0.20 NS
thine
Serum lycopene 0.42 ± 0.41 0.13 ±0.10 <0.01
Serum a-carotene 0.06 ± 0.05 0.03 ± 0.02 <0.05
Serum ß-carotene 0.36 ± 0.30 0.21 ± 0.12 NSP
Total serum carot­ 1.45 ± 0.81 0.86 ± 0.40 <0.01
enoids
lp values denote the chance that values from both groups have the 
same origin (calculated with unpaired two tailed /-test); differences are 
considered significant if p < 0.05. Raman intensity in counts/(15 sec). 
GB, Gall body; x, mean; SD, standard deviation; NS, not signifi­
cant.-2^  arbitrary units.
enoid amounts present in Gall bodies in lymphocytes of healthy 
individuals and lung cancer patients. This was performed on 3 
individuals, one healthy person and 2 advanced lung cancer 
patients (lung adenocarcinoma and squamous cell lung cancer). 
Figure 3a shows the serum carotenoid concentration response 
following supplementation with 100 mg ß-carotene/d ay, as a 
function of time. The results clearly show that all serum carotenoid 
concentration values rise immediately after supplementation and 
continue thereafter. These values in the lung cancer patients were 
lower at the start than those in the healthy volunteer but increased 
to the same values as those in the healthy volunteer after 8 days of 
supplementation, the relative increase in the lung cancer patients 
thus being 2 to 3 times moré marked than in the healthy individual.
The effects of supplementation on carotenoid content in the Gall 
bodies is shown as a function of time in Figure 3. This figure shows 
that the response is comparable in all cases. All baseline levels 
increase by about 50%. Such an increase was observed during the 
first 5 days of supplementation, while the carotenoid concentration 
remained constant thereafter. The amount of carotenoids in Gall 
bodies in both lung cancer patients did not reach the values of the 
healthy individual. This is in contrast with the findings in serum. 
This suggests that carotenoids are not taken up by simple diffusion.
DISCUSSION
The following findings emerge from this pilot study:
a. Raman microspectroscopy is well suited for determining 
carotenoid concentrations inside cells.
b. Intracellular carotenoid amounts in lymphocytes decrease 
with age; in age-matched groups, the carotenoid content of 
lymphocytes is significantly lower in the lung cancer patients.
c. A very weak correlation only exists between the carotenoid 
content in lymphocytes and the serum carotenoid concentration.
d. Carotenoid supplementation restores normal carotenoid con­
centration in the serum, but intracellular values remain significantly 
low (i.e., 50% increase in lymphocyte carotenoid levels and 3- to 
5-fold increase in serum concentration).
The intracellular carotenoid concentration may thus be a more 
accurate parameter than that in the serum.
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Fig. 2 - (a) Concentration of total serum carotenoids (pmoles/I), measured with HPLC. Bars, average ± standard deviation. Difference between 
“all healthy” group and “lung cancer” group is significant (p =  0.006). Difference between “healthy, old” group and “ lung cancer” group is not 
significant (p = 0.72). (b) Concentration of total carotenoids in the Gall body of lymphocytes, measured as Raman intensity [counts/(15 sec); 
every point is an average of 25 measurements in different cells]. Bars, average ± standard deviation. Difference between “all healthy” group and 
“lung cancer” group is significant (p =  0.003). Difference between “healthy» old” group and “ lung cancer” group is significant (p =  0.04).
Fig . 1 - (a) Schematic representation of the Raman microspectro­
scope used in our study. The laser is focused to a spot (0.5 (am in 
diameter) in the cell, using a normal CCD camera and TV for 
determining the exact place. After rejection of the laser line with a filter, 
the Raman scattered light is coupled into a spectrometer, and the 
spectrum of the dispersed light is projected on a liquid N2-cooled 
camera. The spectra are stored using a normal personal computer, (fi) 
Photograph of a lymphocyte containing a Gall body (arrow). Scale 
bar = 2 pm. (c) Topical spectrum from a Gall body of a healthy indi­
vidual. The peak height at 1,150 cm" 1 (background subtracted) is propor­
tional to the carotenoid concentration inside the Gall body (see text).
The results of short-term ß-carotene supplementation show that 
there is no simple relation between serum and intracellularlympho- 
cyte carotenoid content. During ß-carotene supplementation the 
serum carotenoid concentration rises continuously, while there is 
only a small increase in the Gall body carotenoid content during the 
first days. Our observation that Gall body carotenoid concentration 
rises during the first days only is not related to saturation of the Gall 
bodies with carotenoids, since the variation in individual Gall body 
concentrations was not significantly decreased (data not shown). In 
addition, even higher carotenoid contents have been observed in 
other healthy individuals.
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Fig. 3 - (a) Total serum carotenoid concentration response (pmoles/1) to supplementation with 100 mg ß-carotene/day as a function of time. 
Levels on day 0 are basal levels; supplementation was started at day 0.(b) Gall body total carotenoid concentration response measured as Raman 
intensity [counts/(15 sec); each point in the graph is an average over 25 Gall bodies] upon supplementation with 100 mg ß-carotene/day as a 
function of time. Levels on day 0 are basal levels; supplementation was started at day 0.
Our findings are based on a relatively small number of explor­
atory experiments. They suggest that evaluation of intracellular 
carotenoid concentration may provide additional and different 
information, compared with measurements in the serum. Our 
results therefore stress the need to investigate the significance of 
the high carotenoid amounts found in lymphocytes, and they
open novel ways to study the mechanism(s) that may quantitatively 
correlate carotenoids and lung cancer.
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